Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
The best cash back program can help you save money on everyday purchases. Discover credit cards that offer great cash back rewards.
28,001 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A new income-focused ETF challenger has pushed past JEPI by roughly 42 percentage points since its October 2023 debut...
A major institutional bet lands on Birkenstock. Rice Hall James loads 466,577 shares, a roughly $19.8 million stake i...
FuelCell Energy slumped 22% on Monday as investors rebalanced the AI-powered hydrogen rally, with Plug Power down 12%...
If you’re worried about crash artificial headlines in AI stocks, a simple, cost-efficient solution can help: diversif...
Eli Lilly stock could advance in the second half of 2026 as Foundayo gains traction and the GLP-1 franchise shines, b...
Nike faces a pivotal few years as it shifts toward direct-to-consumer and digital growth. This deep dive outlines whe...
The AI spending spree has some investors on edge. This guide explains why three big tech leaders may weather the stor...
Oklo faces a pivotal moment after July. This piece explains a single catalyst investors should watch, the potential s...
Sandisk stock sinking today grabbed headlines as intraday gains faded amid broader market jitters. This article break...
Inflation isn’t just a headline—it's a real market force that tests how consumers spend on discretionary goods. Explo...
Starting with $1,000, you can anchor a tech-forward portfolio on three core players. This guide explains why these co...